Companies Dominating the Behcets Disease Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Gyroscopic Therapeutics
- Novartis AG
- AbbVie
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson
- Panacea Biotec
- Gentech
- Abbott
- Coherus Biosciences Inc,
- R pharm
Browse Key Market Insights with Data Illustration:
In the News
- Pfizer, announced completion its acquisition of Global blood therapeutics. It’s a biopharmaceutical company dedicated to development, discovery and delivering lifesaving treatments that offer hope to patients with non-curable diseases, like sickle cell anemia & Behcet’s disease.
- Gyroscope Therapeutics, announced that Novartis has finalized a deal to purchase all of the outstanding shares of the company. This therapy has the potential to be the first therapy with sustained efficacy for geographic atrophy patient population.
